
Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $1.90 | Prev. Close $1.93 | Circuit Range N/A |
Day Range $1.90 - $1.90 | Year Range $1.34 - $53.17 | Volume 296 |
Average Traded $1.90 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
Day | Open | Close | Change % |
---|---|---|---|
12-Sep-25 | $1.90 | $1.90 | +0.00% |
12-Sep-25 | $1.90 | $1.90 | -1.55% |
11-Sep-25 | $1.81 | $1.93 | +9.04% |
10-Sep-25 | $1.82 | $1.77 | +1.14% |
09-Sep-25 | $1.71 | $1.75 | +0.86% |
08-Sep-25 | $1.69 | $1.74 | +0.87% |
05-Sep-25 | $1.81 | $1.72 | +4.24% |